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a b s t r a c t
G6PD deficiency c563T is the most common inherent blood disease among the Mediterranean populations and its molecular diagnosis is critical as the enzyme assay fails for heterozygous individuals. The
purpose of the study is to estimate the ubiquity of the heterozygous G6PD Med (c563T) variants among
Egyptians and UAE nationals living in Dubai. We validated two molecular methods, polymerase chain
reaction-restriction fragment length polymorphism (PCR-RFLP) and qPCR allelic discrimination assay
for detection of G6PD Med variants. Among 100 screened individuals, G6PD c563T variants are 30% of
whom 15% are carriers. Sanger sequencing validated the qPCR discrimination assays. In search of a phenotypic marker to detect G6PD heterozygous variants, inheritance of G6PD locus and red-green color
vision genes is studied in 1 Egyptian and 2 Emirati families. Among the 3 families, G6PD is polymorphic,
displaying 4 phenotypes: in phenotype-1, person is normal, in phenotype-2 the person has no G6PD deficiency but with deuteranopia/deuteranomaly, in phenotype-3 the person is G6PD Med variant with
deuteranopia/deuteranomaly and in phenotype 4 the person is G6PD Med variant has normal vision.
Based on the molecular analysis of G6PD and Ishihara vision test it can be concluded that the two mutations at the two loci arose independent of each other without any interaction (epistatic effect) between
them. Following the pedigree analysis of the two genes for 4 generations it is presumed that it is infeasible to use ‘‘deuteranopia /deuteranomaly” as a phenotypic marker to detect G6PD c563T heterozygous
individuals among the Egyptian populations.
Ó 2021 Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

1. Introduction
⇑ Corresponding author.
E-mail addresses: Lina.maloukh@zu.ac.ae (L. Maloukh), alagappan@neoscience.
ae (A. Kumarappan),
Lakshmibeaconhouse@hotmail.com,
v.lakshmi@ums.ae
(R.L. T.V.).
1
Both are the first authors.
Peer review under responsibility of King Saud University.

Production and hosting by Elsevier

The long arm of human X chromosome is gene and CpG rich.
Among the X linked genes at q28 telomere, G6PD encodes a metabolic enzyme crucial in the pentose phosphate pathway, provides
NADPH that protects the red blood cells from reactive oxygen species (Nkhoma et al., 2009). G6PD gene is remarkable for its genetic
diversity with 217 mutations of which 182 (83.9%) are single
nucleotide mutations (Gómez-Manzo et al., 2016). Mediterranean
mutation (Class II of G6PD), the most common variant among the
Mediterranean populations, is a point mutation of C/T substitution
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free water; is set at 37°C for 30–45 min. The digested amplicons
were visualized on 2% agarose gel electrophoresis with 100 bp
marker. The 547 bp long amplicon from a healthy person upon
MboII digestion yields 2 visible bands of 377 and 119bps; while
those of Med variants yield bands of 277, 119 and 100 bps respectively (as shown in Figure-1).

at nucleotide 563 in the gene, with a switch of serine/phenyl alanine at amino acid 188 in the G6PD enzyme (Al-Ali et al., 2002;
Alfadhli et al., 2005; Al-Musawi et al., 2012; Karimi et al., 2003;
Vulliamy et al., 1988).
Diagnosis of G6PD Med variants (c563T) in the heterozygous
females gives rise two possible scenarios: (1) if the X chromosome
with mutant allele is inactive, the female would have normal
G6PD enzyme, with mutant allele eclipsed, (2) but if the X chromosome with normal allele is inactivated the woman would be G6PD
enzyme deficient. Because of this complication, molecular techniques for flawless diagnosis of the G6PD Med variants are mandatory (Arnaout et al., 2011). The primary objective of the present
study is to detect the Mediterranean heterozygous carriers (c563T)
accurately through molecular techniques among UAE nationals
and Egyptians inhabiting in Dubai (UAE).
There are a few genetic studies describing the linkage disequilibrium between G6PD and the red green color vision genes. Wild G6PD
allele is linked with the color vision genes in Sardinia and Turkish
people (Filippi et al., 1977; Yücel et al., 1992), while the mutant allele
of G6PD is similarly linked among Italian, Greek and Chinese populations (Filosa et al., 1993; Fraser et al., 1963; Wu et al., 1988). However, there are no reports of such linkage among the Mediterranean
populations; in an attempt to maneuver red-green color blindness as
phenotypic marker to detect the G6PD c563T Med carriers, 3 Arabian
families (1 Egyptian and 2 Emirati) with G6PD deficiency are
screened for their color vision; pedigrees are constructed for the
three families up to 4 generations in the present study.

2.3. Allelic discrimination assay
TaqmanÒ allelic discrimination assay was performed in Bio-Rad
CFX96 thermal cycler (CFX96 iCycler TouchTM system). The assays
included unlabeled forward and reverse primers along with two
fluorescent TaqManÒ probes which were designed following GenBank Accession No: X55448 and Primer 3 online software (Rozen
and Skaletsky, 2000). TaqManÒ probe of wild allele was labeled
with FAM reporter dye at 50 end and quencher BHQ1-30 at the 30
end; the probe of the mutant allele (c563T) was with HEX reporter
at 50 end, and quencher BHQ1-30 at the 30 end (Table 1). The FAM
probe specifically binds to the wild amplicon and HEX probe binds
to the mutant amplicon which are generated during PCR amplification and each selectively reports the respective allele.
From the results of PCR-RFLP, the samples of 10 people (5 of the
affected and 5 healthy) were further analyzed through qPCR. After
conforming the results of the 10 people, cheek saliva samples of
3Arabian families (n = 26) were collected and were assayed
through qPCR.
Each real time PCR reaction mixture of 20 ll contained: 10 ll
2X TaqManÒ genotyping master mix (ABI Applied Biosystems),
1 ll of forward primer, 1 ll of reverse primer, 1 ll of each wild
probe and/or mutant probe, 1 ll of genomic DNA (60–80 ng/ll)
and 5 ll of nuclease-free water. The concentration of genomic
DNA (60–80 ng/ll) was so chosen after standardization, as they
did not affect melting profiles. The reaction mixtures were loaded
in a 96 well Bio-Rad Real time PCR system, a sample of negative
control (no DNA template with water), was also included. The
PCR conditions were: 1 cycle of denaturation at 94°C for 10 min,
followed by 35 cycles of 94°C for 30sec, and 60°C for 45sec and
Melt curve at 50–85°C. PCR program was run on allelic discrimination setup and the results were analyzed through discrimination
curves. After PCR amplification, in the healthy person with CC
genotype, FAM will fluoresce showing red peaks, in the affected
TT genotype HEX will fluoresce showing blue peaks and the
heterozygous with both peaks on the screen. All qPCR reactions
were done in triplicate and final quantification cycle (Cq) values
were the means of 3 samples.

2. Materials and methods
2.1. Sample collection and genomic DNA extraction
Sterilized swabs (n = 100) were used to collect the cheek saliva
samples from each person under aseptic conditions into sterile
ethylene diamine tetra-acetic acid (EDTA) vials. Genomic DNA
was extracted from all the samples with Qiagen genomic DNA isolation kit (lot No. 69581) following the manufacturer’s instructions
and the DNA is stored at 20⁰C for further analysis.
2.2. Detection of G6PD c563T mutation by PCR-RFLP
PCR conditions and restriction enzyme digestion are as mentioned by Ezz El-Deen’s group (Ezz-El-Deen et al., 2013). PCR reaction was set with specific primers to amplify the DNA for healthy
and G6PD c563T variants (Table 1). PCR reaction mixture of 25 ll
contained: 12.5 ll of 2X PCR Master mix, 1 ll of Forward Primer,
1 ll of Reverse Primer, 9.5 ll nuclease-free water, and 1 ll template DNA (60–80 ng/ll). PCR (T100 BioRad, USA) conditions were
as follows: 1 cycle (94 °C for 3 min), 30 cycles (94 °C for 45 sec, at
62 °C for 45 sec, at 72 °C for 1 min) and 1 cycle at 72 °C for 7 min.
Each PCR product was digested with MboII restriction enzyme
(NEB, lot No. R0148S), 20 ll mixture contained 2 ll of the PCR
amplicon, 1 ll of MboII, 2 ll of 10X buffer and 15 ll of nuclease

2.4. DNA sequencing
After detecting the c563T mutant samples, a 50 ml reaction is set
for PCR amplification with the primers used in qPCR reaction. The
reaction mixture of 50 ml contained : 25 ml of Taq PCR Master Mix
(Norgen Biotek, Canada), 1 ml of the DNA template (50–80 ng/ ml)
from the mutant samples, 1 ml forward primer 50 - CTGGAACCG-

Table1
The primer sets and/or probes used in the PCR-RFLP and qPCR methods.
Name of Primer/probe
Forward Primer
Reverse Primer
Forward Primer
Reverse primer
Probe – Wild type
Probe-Mutant type

Sequence for c563T mutation
PCR-RFLP
50 -ACTCCCGAAGAGGGGTTCAAGG-30
50 -CCAGCCTCCCAGGAGAGAGGAAG-30
Allelic Discrimination Assay
50 - CTGGAACCGCATCATCGT 30
50 - GGTTCTGCACCATCTCCTT 30
50 -FAM-CAACCACATCTCCTCCCTGTTCC –BHQ1-30
50 -HEX- CCAACCACATCTTCTCCCTGTTCC –BHQ1-30
2

Length (nt)

Restriction enzyme

22
23

MboII (NEB)
MboII (NEB)
–
–
–
–
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CATCATCGT 30 (10 mM), 1 ml reverse primer 50 - GGTTCTGCACCATCTCCTT 30 (10 mM) and 22 ml distilled water. The PCR conditions were as follows 1 cycle (94°C for 3 min), 35 cycles (94°C for
1 min, 60°C for 1 min, 72°C for 1 min) and 1 cycle 72°C for
7 min. Amplified PCR products were checked on 1.5% agarose gel
electrophoresis for the 150 bp bands; were sent to Macrogen
(Seoul, South Korea) for DNA sequencing. The obtained forward
and reverse sequences were aligned by using online Pairwise alignment tool and submitted to NCBI BLAST search for identification of

Color vision was checked for the family members with Ishihara
38 plates test following the test instructions (Birch, 1985). Individuals who read 13 plates or less are red green color blind while
those who read 17 or correctly were diagnosed to have normal
vision; there were no individuals who read 14–16 plates correctly.
The results were further confirmed by Ishihara 38 plate test done
by Global health Bureau, (USAID) for the affected individuals.

the query sequences (www.ncbi.com) and submitted to GenBank
are with Accession number- MT975591.

3. Result

2.6. Color blind test

2.5. Pedigree analysis among the 3 Arabian families 1 Egyptian and 2
Emiratis

3.1. Detection of G6PD c563T variants by PCR-RFLP
The PCR amplified DNA (n = 100) with specific primers yielded
a ~ 550 bp fragment could be visualized on 2% agarose gel (Fig. 1,
uncut). The PCR product after restriction digestion with MboII for
45 mins, yielded 2–4 fragments in electrophoresed gel: for a normal person 2 visible bands of 377 bp and 119 bp (Fig. 1 healthy),
for mutant males and for mutant homozygous females three bands
viz, 277 bp, 119 bp and 100bps (Fig. 1 affected) and for heterozygous females (carriers) 4 fragments of 377 bp, 277 bp, 119 bp
and 100 bp (Fig. 1 Carrier). As expected the mutation C ?T creates
an MboII site where the restriction enzyme cleaves the 377 bp DNA
band into two bands of 277 bp and 100 bp. From a total of 100
samples, 70 are healthy, 30 are affected, and of who 15 are hemizygous and homozygous (male and female) while 15 of them are
heterozygous carriers. The gel observed results of healthy and
c563T variants are consistent with Sequencing, GenBank accession
number MT975591 (see Fig. 2).

After screening the cheek saliva samples for c563T variant, fresh
samples were collected from G6PD affected family members
(n = 26) viz., grandparents, parents, children and grandchildren
for 1 Egyptian and 2 Emirati families. The analysis was repeated
for the samples employing real time PCR discrimination assay
and Sanger sequencing. The Egyptian family members were thirteen, and those of Emirati were eight and five respectively.

3.2. Detection of G6PD c563T variants by TaqManÒ qPCR
The TaqManÒ PCR results of the 10 samples are shown in figure2 and those of the Arabian families in table-2.
3.3. Inheritance of c563T mutation and color blindness in the 3
families:
3.3.1. Inheritance of c563T mutation in Egyptian family (1)
The family included thirteen members over four generations from
grandparents (P) to great- grandchildren (F3). The members are 2

Fig. 1. PCR-RFLP (MboII) assay of healthy and c563T homozygous and heterozygous
variants. Size marker (M) 50 bp.

Fig. 2. Genotyping for G6PD c563T variants through TaqManÒ qPCR. X-axis represents the relative fluorescent emission (Cq: quantification value) for the wild allele (CC) - the
specific probe labeled with FAM reporter, while the Y-axis represents (Cq value) for the mutant allele (TT) - specific probe labeled reporter HEX. The three groups indicate
three different genotypes of G6PD normal and variants; red indicates normal homozygous wild allele, green indicates heterozygous c563T variant, blue indicates homozygous
TT affected and white is negative control.
3
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(F2), son is deutan color blind, while daughter is normal visioned
(carrier). The Deuteranope son married a normal visioned lady;
his 2 sons (in F3) had normal vision. The carrier mother (in F2),
passed the defective MW gene/s to two of three children in F3,
son is deuteranope and the daughter is normal visioned (carrier,
Fig. 3).
Based on the molecular results and Ishihara 38 plate test, 3 haplotypes could be deduced from the family members. In the haplotype 1 both genes G6PD and LW and MW are normal (males in
F3), in haplotype-2, normal G6PD allele is linked with defective
or anomalous MW gene/s (man in P), in haplotype-3, c563T allele
is linked with defective or anomalous MW gene/s resulting in
deuteranopia/deuteranomalous (male in F2 and F3), as shown in
Table-3. The G6PD gene (normal/c563T variant) is coupled with
MW opsin gene/s at Xq28 (normal/ deutan type) for 4 generations
from P to F3 generations (Fig. 3).

parents in (P), 1 daughter (F1), 2 grandchildren (F2) and 5 greatgrandchildren (F3). Allelic discrimination assay qPCR of G6PD gene
revealed 7 members healthy, 4 heterozygous carriers and 2 hemizygous (Table 2). The heterozygous carriers are grandmother, daughter
(F1), granddaughters in F2 and F3 generations; while the hemizygous Med mutants are grandsons in F2 and F3 (Fig. 3).
3.3.2. Inheritance of red-green color blindness
The Ishihara 38 plate test (Global health Bureau, USAID) of the
family (n = 13) revealed that male parent (in P), daughter (in F1),
grandson (in F2) and maternal great grandson (in F3) are Deuteranopes (the result of great grandson in F3, Supplementary S-1).
Pedigree analysis discloses that the father in P generation is
color blind-deuteranope, his daughter (F1) is deuteranope,
inherited the defective genes from both the parents. The deuteranope mother in F1, passed the defective gene to both her children

Table 2
Genotyping of 3 Arabian families through qPCR assay.
Family

No of members

Normal G6PD

Homozygous G6PD

Heterozygous G6PD

Hemizygous c563T

Egyptian
Emirati

13
13

7 (53.8%)
3(23%)

–
3 (23%)

4 (30.7%)
4 (30.7%)

2 (15.3%)
3 (23%)

Fig. 3. Pedigree of Egyptian family for 4 generations, showing the inheritance of G6PD/c563T and normal/red-green color vision genes. (For interpretation of the references to
colour in this figure legend, the reader is referred to the web version of this article.)
4
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Fig. 4. Pedigree of the Emirati families showing the inheritance of G6PD/ c563T and normal/red-green color vision genes for two generations. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this article.)

Table 3
Phenotype and deduced haplotype of G6PD/ c563T and normal/ red-green color blindness loci among the 3 Arabian families.
Family

Phenotypes

Deduced Haplotype

Linkage between G6PD and red-green loci

Egyptian
,,
,,
Emirati

Phe-1
Phe-2
Phe-3
Phe-4

XCN
XCD
XTD
XTN

wild G6PD allele with normal LW and MW
wild G6PD allele with defective MW
c563T with defective MW
c563T with normal LW and MW

no G6PD deficiency, normal vision
no G6PD deficiency, deuteranopia
Med variant, deuteranopia
Med variant, normal vision

Phe = Phenotype.

detect homozygous, heterozygous and hemizygous Med individuals, as it is quicker, many samples could be analyzed simultaneously without the need of restriction enzyme and gel analysis.
Since G6PD deficiency is the most common blood disorder,
newborn and young children with clinical symptoms are often
tested for the enzyme efficiency. The Med variants are 33% among
Egyptian neonates, while it is 62% in older children (Ezz-El-Deen
et al., 2013; Arnaut et al., 2011), 95% of 21 Arabs (Kurdi-Haidar
et al., 1990) and 50% of 1189 Greeks (Molou et al., 2014), Our test
system established 30% Med variants included Egyptians and Emiratis of age groups 20–75 years. The differences in the per cent of
Med variants in our study compared to the previous reports could
be due to the reasons: 1) it included individuals of age groups up to
75 years 2) both sexes and 3) variation in the sample size.
Sequence polymorphisms and mRNA analysis were often used
to designate the inactivated X chromosome in females. In this context, the silent mutation 1311C/T in exon 11 of G6PD gene was
explored as a molecular marker which was common among 40%
of all ethnic populations (Prchal et al., 1993). The wild nt 1311C
and mutant 1311 T are observed in both G6PD-normal and deficient populations; hence the association of C1311T with G6PD
Med mutations is studied in different populations (Moiz et al.,
2009). The G6PD c563T variant is associated with the C1311T
mutation in 28.6% and 77% among Egyptian children (Arnaout
et al., 2011; Ezz-El-Deen et al., 2013) and 95.2% among Palestinians
(Sirdah et al., 2012). However in such investigations, molecular
analysis of both the regions (c563T and C1311T) had to be carried
to determine the inactivated X chromosome; in search of an alternative marker, the red-green color blindness is explored to detect
c563T variants in the current investigation.
In the present study, the pedigree analyses of the 3 Arabian
families for the G6PD as well as the green gene are found to be
dimorphic. The observed phenotypes and dimorphism are not

3.3.3. Inheritance of c563T mutation in Emirati families:
In one Emirati family, the 8 members are father, mother and six
children. qPCR allelic discrimination assay revealed the mother, 2
of the daughters are carriers and 2 of the sons are G6PD c563T
affected (Fig. 4, family-2). qPCR assay of this family revealed the
father and the 3 daughters are affected while the mother is carrier
of G6PD c562T (Fig. 4 family-3). Sanger sequencing validated the
G6PD c563T variants.
The genotyping of the 13 members of the 2 Emirati families is, 3
are healthy, 4 heterozygous carriers and 6 are affected (Table 2).
3.3.3.1. Inheritance of red-green color blindness in the Emirati
families:. The color vision test revealed all of them (n = 13) to have
normal vision (Table-3). Based on the results of qPCR assay and
Ishihara 38 plate color vision test, the pedigree of the two families
could be deduced as shown in Fig. 4. G6PD c563T variant is coupled
with normal MW opsin gene/s in the Xq28 for 2 generations
(Table 3).
In each generation, different colors are used to distinguish the
maternal X chromosome from the paternal X chromosome. XC
allele for normal G6PD and XT allele for the c563T variant; XN for
normal vision, and XD for color blindness Deuteranopia or
Deuteranomaly.
4. Discussion
Over the last few decades, there has been a lot of information on
G6PD variants among Arabic populations, when hemolytic anemic
patients were usually screened. The common practice for the
detection of G6PD variants is through enzyme assay and/or
PCR-RFLP molecular method. In our study, we used two molecular
techniques, between them we recommend the qPCR technique to
5
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unique to Egyptian and Emirati families as they were detected
among Turkish, Singaporeans and Thais. Phenotypes 2 and 4
were observed among Turkish men and women (Yücel et al.,
1992) and Thai males (Soontarawirat et al., 2017), while phenotypes 2, 3 and 4 were documented among pre-enlistees men
(Chan et al., 1992). However, in these studies G6PD deficiency
was diagnosed through enzyme assay, neither Ishihara test was
used to distinguish between the protan and deutan type vision
defects. In the pedigree of the Egyptian family deuteranopia is
not always associated with c563T mutation, hence this defective
vision is not a useful phenotypic marker to detect the G6PD
c563T variant. Soontarawirat’s group (2018) opined that color
blindness was not informative to detect the G6PD Mahidol variant
among Thai people. Our results are similar to those observed
among Thais, though the two mutations/variants of G6PD are different. Molecular characterization of the MW gene/s is needed to
divulge the cause of the deuteranopia in the Egyptian family.
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5. Conclusions
However, based on the molecular analysis of G6PD gene and
Ishihara 38 plate color vision test, the following conclusions are
drawn from 26 members of 3 Arabian families studied- 1. The
two loci are polymorphic (dimorphic) 2. It is evident from the pedigree study that mutations occurred at the two loci independently
without any epistatic effect 3. There is strong linkage disequilibrium between the two loci, were inherited up to 4 generations 4.
Deuteranopia cannot be chosen as a phenotypic marker to detect
G6PD Mediterranean mutation, warranting investigation in larger
samples.
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